If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVan Elle Regulatory News (VANL)

  • This share is currently suspended. It was suspended at a price of 52.00
  • There is currently no data for VANL

Form 8 (OPD)

22 Apr 2026 11:26

RNS Number : 5167B
Van Elle Holdings PLC
22 April 2026
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Van Elle Holdings plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

n/a

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Van Elle Holdings plc

(d) Is the discloser the offeror or the offeree?

OFFEREE

(e) Date position held:

The latest practicable date prior to the disclosure

22 April 2026

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

Ordinary shares of 2 pence each

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

Nil

Nil

Nil

(2) Cash-settled derivatives:

 

Nil

Nil

Nil

Nil

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

Nil

Nil

Nil

 

TOTAL:

Nil

Nil

Nil

Nil

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

None

Details, including nature of the rights concerned and relevant percentages:

None

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

Interests of directors

 

Name

Number of Shares

Percentage existing issued ordinary share capital as at the Last Practicable Date

Mark Cutler and spouse

1,067,428

1.0%

Graeme Campbell and spouse

75,000

0.1%

Francis Nelson and spouse

190,000

0.2%

Charles St John

100,000

0.1%

David Hurcomb

65,000

0.1%

Total

1,497,428

1.4%

 

Share awards and options held by directors of Van Elle Holdings plc

 

Long Term Incentive Plan1

Scheme

Grant Date

Normal Vesting Date

Exercise Price (£)

Number of Shares in respect of Awards

Mark Cutler

 

2020 LTIP *

Sep-20

Sep-23

0.02

419,471

2023 LTIP**

Sep-23

Sep-26

0.02

733,084

2024 LTIP**

Sep-24

Sep-27

0.02

759,804

2025 LTIP**

Sep-25

Sep-28

0.02

812,805

Total

 

2,725,164

 

Graeme Campbell

 

2020 LTIP *

Sep-20

Sep-23

0.02

242,852

2023 LTIP**

Sep-23

Sep-26

0.02

416,415

2024 LTIP**

Sep-24

Sep-27

0.02

431,593

2025 LTIP**

Sep-25

Sep-28

0.02

461,699

Total

 

1,552,559

 

* Awards which have vested and not yet been exercised.

** Awards for which the performance period is ongoing.

 

Save As You Earn

 

Grant Date

Normal Vesting Date

Exercise Price (£)

Number of Shares in respect of Award

Mark Cutler

Mar-23

Apr-26

0.404

44,554

Total

 

44,554

 

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

22 April 2026

Contact name:

Graeme Campbell (Chief Financial Officer)

Telephone number:

+44 (0)1773 580 580

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEEEAELAAASKEFA
Date   Source Headline
10th Dec 20187:00 amRNSHalf Year Trading Update
19th Oct 20181:11 pmRNSDirector/PDMR Shareholding
18th Sep 20184:55 pmRNSResult of AGM
31st Aug 201810:34 amRNSHolding(s) in Company
13th Aug 20181:00 pmRNSDirector/PDMR Shareholding
26th Jul 20184:43 pmRNSDividend record date
25th Jul 20187:00 amRNSFinal Results
18th May 20187:00 amRNSDirector/PDMR Shareholding
16th May 20181:09 pmRNSDirector/PDMR Shareholding
3rd May 20187:00 amRNSTrading update and CEO succession process
25th Jan 20187:00 amRNSHalf-year Report
19th Jan 20183:07 pmRNSHolding(s) in Company
16th Jan 20189:05 amRNSSecond Price Monitoring Extn
16th Jan 20189:00 amRNSPrice Monitoring Extension
16th Jan 20187:00 amRNSStatement re: Carillion plc
8th Jan 20183:11 pmRNSHolding(s) in Company
15th Dec 20174:54 pmRNSResults of General Meeting
5th Dec 20177:00 amRNSBoard response to the Ellis statement
29th Nov 20177:00 amRNSPosting of Circular to Shareholders
22nd Nov 20177:02 amRNSNotice of GM
22nd Nov 20177:01 amRNSDirectorate Change
22nd Nov 20177:00 amRNSTrading Update
13th Nov 20177:00 amRNSRequisition of General Meeting
1st Nov 20177:00 amRNSAppointment of Non-Executive Director
12th Sep 20173:12 pmRNSResult of AGM
12th Sep 20177:00 amRNSAGM Trading Update
21st Aug 20174:20 pmRNSNotice of AGM
26th Jul 20177:00 amRNSFinal Results
6th Jun 20177:00 amRNSHolding(s) in Company
25th May 20177:00 amRNSTrading Update
5th May 20177:00 amRNSDirector/PDMR Shareholding
27th Apr 20177:00 amRNSDirector/PDMR Shareholding
3rd Apr 20177:00 amRNSDirector/PDMR Shareholding
23rd Mar 20175:27 pmRNSHolding(s) in Company
22nd Mar 20177:00 amRNSTrading Update
6th Mar 20177:00 amRNSDirectorate Change
19th Jan 20177:00 amRNSHalf-year Report
23rd Dec 20167:00 amRNSBoard Change
8th Dec 20167:00 amRNSTrading Update
26th Oct 20167:00 amRNSAdmission and First Day of Dealings on AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.